Dr John Bridgewater trained in Oxford and University College London qualifying in 1986. He further trained in Medical Oncology at the Middlesex, Royal Free, Mount Vernon and Royal Marsden Hospitals. He obtained a PhD thesis in gene therapy at the Institute of Cancer Research 1996. He was appointed as a Senior Lecturer in Medical Oncology at UCL in 1999. He also visits the North Middlesex and Princess Alexandra Harlow hospitals.
Dr Bridgewater specialises in gastrointestinal oncology, with a particular interest in biliary tract cancers and carcinomas of unknown primary origin. He leads the National Cancer Research Institute subgroup in bilary tract malignancy and is actively involved in the research portfolio. He is also active in trials across the gastrointestinal portfolio and is a member of the European Organisation for Research and Treatment of Cancer. He has a laboratory programme investigation Carcinoma of Unknown Primary based at the UCL Cancer Institute.
Visit his website,
for more information.